Israel-U.S. - Health Innovation Dialogue



Time Zone


Target Audience

Target Audience

Israel and U.S. Health tech community: Start ups, companies and research institutes as well as anyone who is interested in new information on R&D programs by the Israel Innovation Authority or the US Federal Entities


Life Sciences
Medical Devices
Medical technology
See you on Zoom!

About the Event

This forum is part of the official U.S.-Israel Innovation Forum and will bring together leaders from American and Israeli government, business, and research institutions, for discussion on emerging policy and technology issues in health care and opportunities for expanded U.S.-Israel partnerships in health innovation.

The U.S.-Israel Innovation Forum is taking place under the Technological Innovation and Entrepreneurship Memorandum of Understanding between the Israel Innovation Authority and the U.S. Department of Commerce.
The forum is organized and hosted by the Israel Innovation Authority, the U.S. Department of Commerce, the Economic & Trade Mission at the Embassy of Israel, and the US Chamber of Commerce. 


15:30-16:00 (ILT) | 08:30-09:00 (EST)

Opportunity for U.S.- Israel Health Partnership and Innovation

  • Introduction (5 minutes) - Khush Choksy, Senior Vice President, Middle East Affairs, U.S. Chamber of Commerce
  • Keynotes: Building A Stronger U.S.-Israel Health Relationship (15 minutes) - Dr. Asher Salmon, Director, International Relations Division, Israel Ministry of Health, Dr. Rachel Levine, Assistant Secretary of Health, U.S. Department of Health and Human Services
  • Moderated Discussion: (10 minutes) - with Representative Chris Pappas (D-NH)
    • Moderator: Ileana Ros-Lehtinen, Senior Advisor, Akin Gump, Former Chairwoman, House Foreign Affairs Committee
16:00-17:00 (ILT) | 09:00-10:00 (EST)

Opportunities for Digital Health Technology in Clinical Trials

Digital (mobile) health technology offers many potential opportunities for clinical trials, including the acquisition of frequent or continuous data directly from patients wherever they are. This session will explore the opportunities to measure drug efficacy in clinical trials using sensor and other technologies. The session will also address some of the challenges to the widespread implementation of mobile health and explore opportunities to continue to improve the landscape for bilateral commercial health cooperation.    

  • Dr. Osnat Luxenburg, Head of the Medical Technology, Innovation, Health Information, and Research Directorate, IL Ministry of Health 
  • Dr. Leonard Sacks, Associate Director for Clinical Methodology, Office of Medical Policy, U.S. Food and Drug Administration (FDA)
  • Professor Eyal Zimlichman, Deputy Director General, Chief Medical Officer and Chief Innovation Officer, Sheba Medical Center
  • Trevor Gunn, Vice President, International Relations, Medtronic
    • Moderator: Esti Shelly, Head of the Digital Health Division, Israel’s Ministry of Health
17:00-18:00 (ILT) | 10:00-11:00 (EST)

Exploring Partnerships in Bio-convergence

This session would focus on the newly emerging area in health contributing to major advances and progress in a range of health challenges.  Look at Israel’s National Bio-convergence Initiative and understand developments in the U.S. government and private sector around bio-convergence.

  • Dr. Christopher Houchens, Director Division of CBRN Countermeasures, Biomedical Advanced Research and Development Authority (BARDA)
  • Dr. Mikael Dolsten, Chief Scientific Officer and President, Worldwide Research, Development and Medical, Pfizer
  • Dr. Sheng Lin-Gibson, Chief of the Biosystems and Biomaterials Division, National Institute for Standards and Technology (NIST)
    • Moderator: Anya Eldan, VP Startup Division and Business Development, Israel Innovation Authority
18:00-18:20 (ILT) | 11:00-11:20 (EST)

Models for U.S.-Israel Health Cooperation

Panelists will present innovation platforms for collaboration in the healthtech domain, including the Medical Technology Enterprise Consortium (MTEC) and the Thomas Jefferson Israel Center.  These new models demonstrate public-private partnerships in U.S.-Israel health innovation and cooperation and provide practical insights on expanding cooperation in this important sector.

  • Bill Howell, President, Medical Technology Enterprise Consortium (MTEC)
  • Dr. Zvi Grunwald, CEO, Jefferson Israel Center
    • ModeratorNili Shalev, VP International Division, Israel Innovation Authority 


18:20-18:30 (ILT) | 11:20-11:30 (EST)


  • Josh Kram, Managing Director, U.S.- Israel Business Council, U.S. Chamber of Commerce


The registration to this event is closed
See you on Zoom!